Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
2011 ◽
Vol 55
(4)
◽
pp. 858-865
◽
2016 ◽
Vol 40
(5)
◽
pp. 692-700
◽
2012 ◽
2014 ◽
Vol 50
(10)
◽
pp. 963-970
◽
2016 ◽
Vol 22
(13)
◽
pp. 3652
◽
2014 ◽
Vol 9
(2)
◽
pp. 258-268
◽
2016 ◽
Vol 48
(4)
◽
pp. 1041-1044
◽